HealthAratus Intelligence

iRhythm

iRhythm
iRhythm Intelligence Room

iRhythm Intelligence

What the accumulated evidence, deployment record and lived experience actually show.

Intelligence lenses

Four ways of interrogating the same reality. Each changes the question, not the subject.

What is becoming different about iRhythm over time?

Not enough activity across time yet to describe how this reality has moved.

What we know · what we don’t

Everything here is open to being corrected by someone who has seen it first-hand.

What we still don’t know

Nobody has answered these yet. Your experience can help us understand what is happening.

Unresolved

We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.

Not yet answered

What are we missing?

Matters of record

Settled elsewhere. Context for reading the above, not something practice can confirm.

  • 9 public external signal(s) across 5 source(s).Recorded by HealthAratus

Tool intelligence

What HealthAratus understands

HealthAratus currently understands iRhythm through regulatory records, deployment evidence, company records and external market activity.

Category
imaging_diagnostics

What HealthAratus is still learning

HealthAratus is beginning to understand iRhythm. As evidence and experience accumulate, what remains unclear will be stated here.

Evidence & claims

What this is built on

The material the questions above were built from, with its attribution.

The Zio system is a wearable patch that records continuous ECG data for up to 14 days. Proprietary software analyzes this data to generate diagnostic reports for clinicians.According to iRhythm

What iRhythm states

The vendor’s own claims. Testable where practice can actually test them.

Stated capability

The Zio platform uses deep learning algorithms to analyze recorded cardiac data.

According to iRhythm

Does this change your workflow?

Independent and public evidence

Found in public sources. Not a clinician’s experience, and never presented as one.

Reported deployment

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

According to HIT Consultant

How widely is this actually used?

Reported deployment

Sensor-Based Monitoring of Knee Osteoarthritis Symptoms in Free-Living Settings: Scoping Review

According to JMIR Medical Informatics

How widely is this actually used?

Reported deployment

Artificial Intelligence for Diagnosing Periodontitis and Monitoring Gingival Inflammation

According to ClinicalTrials.gov AI

How widely is this actually used?

Reported deployment

Scaling Wireless Continuous Vital Sign Monitoring Across an 8-Hospital Health System: Digital Health Implementation Report

Reported publicly

How widely is this actually used?

Reported outcome

Digital Quality Monitoring for Type 2 Diabetes in Swiss Primary Care: Qualitative Interview Study

According to JMIR Medical Informatics

Are you seeing this result?

Company participation

Not yet verified

A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.

Claim your company profile

Reference

The stable facts, for interpreting everything above.

Overview

What it does

• Product Overview: iRhythm Technologies provides Zio ECG monitors, wearable devices designed for continuous cardiac monitoring, enabling the detection and analysis of arrhythmias over extended periods. • Technical Functionality: The Zio system comprises a comfortable, easy-to-wear patch that records…

Vendor & external product information, not independently verified by HealthAratus

Where it's used

Deployed in mixed settings, US, UK, Japan, Austria, Netherlands, Spain

Key strength

Regulatory: FDA 510(k) cleared, CE Mark Class IIa, UKCA marked, Japan Medical Device Approval

Key capabilities

Continuous 14-day ECG monitoring, Wireless data transmission to ZEUS platform, AI-driven arrhythmia detection

Clinical use cases

Detection of atrial fibrillation in primary care settings, Monitoring of post-operative cardiac patients, Long-term arrhythmia surveillance in cardiology clinics

Who uses it

Cardiologists, Primary care physicians, Electrophysiologists

Parent Company
iRhythmvendor
1 tracked tool

How the reality here has changed

Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of iRhythm accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.

Across the category

iRhythm against the rest of Imaging & Diagnostics

Category intelligence reads this as Established. A sample of peers, not a census of the category.

Where iRhythm may differ

Differences in what we have recorded. Never a ranking, never a quality judgement.

  • No first-hand account has been recorded for iRhythm or for any peer we sampled in this category.

    A gap across the whole category, not a fact about this technology.

Two readings that disagree

  • Category intelligence reads clinical reality here as "Expanding", yet no first-hand account appears in the systems we sampled. Both readings are shown rather than reconciled.

Used another system in Imaging & Diagnostics? How does your experience compare?

A comparison across two systems tests the category, not just one product.

See the whole Imaging & Diagnostics record

Connected intelligence